In late 2023, the FDA added more than a dozen peptides including both BPC-157 and thymosin alpha 1 to its list of substances that should not be compounded because the agency has identified potential significant safety risks. For BPC-157, the agency warned that the peptide could trigger an immune response
Because Dihexa has no established human dose, "cost per dose" math depends entirely on community-reported figures rather than any validated protocol so per-mg comparisons of the raw material are the cleaner way to compare listings
A peptide is just a short chain of amino acids the same building blocks that make up the protein in your chicken breast or whey shake
Anti-DNA idiotypes: from induction of disease to novel therapeutical approaches
Whether treating a chronic condition or optimizing health, most patients can benefit from peptide therapy
From 3D printed implants designed to match specific anatomy to robotic-assisted navigation that ensures near-perfect accuracy, these technologies are making procedures safer and more predictable
